GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 13 filers reported holding GENETIC TECHNOLOGIES LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $69,962 | +89.1% | 76,881 | +148.2% | 0.00% | – |
| Q3 2022 | $37,000 | -37.3% | 30,980 | -40.1% | 0.00% | – |
| Q2 2022 | $59,000 | -57.9% | 51,703 | -27.2% | 0.00% | – |
| Q1 2022 | $140,000 | -55.1% | 70,993 | -57.2% | 0.00% | – |
| Q4 2021 | $312,000 | +40.5% | 165,920 | +130.2% | 0.00% | – |
| Q3 2021 | $222,000 | -63.1% | 72,072 | -49.1% | 0.00% | – |
| Q2 2021 | $602,000 | +20.2% | 141,626 | +18.1% | 0.00% | – |
| Q1 2021 | $501,000 | -51.9% | 119,927 | -58.6% | 0.00% | – |
| Q4 2020 | $1,042,000 | +151.1% | 289,424 | +141.4% | 0.00% | – |
| Q3 2020 | $415,000 | – | 119,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |